Global Biosurfactants Market 2022
- Market Report
- ID: HC24346G
- Delivery Time: 1 Business Day
- Tag: Biosurfactants
Description
Biosurfactants, which are surface-active agents that have the ability to reduce both surface and interfacial tension, have been found useful for several purposes. Its application within the food industry has proven that it can sustainably replace the utilization of synthetic surfactant in food production processes and products. According to a report by StrategyHelix, the global biosurfactants market is set to increase by US$ 790.6 million during 2022-2028, growing at a CAGR of 5.2% during the forecast period.
The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for biosurfactants. The global biosurfactants market is segmented on the basis of product, end user, and region. On the basis of product, the global biosurfactants market has been segmented into alkyl polyglucosides (APG), sorbitan esters, sucrose esters, rhamnolipids, sophorolipids, methyl ester sulfonates (MES), others. Among these, the MES segment was accounted for the highest revenue generator in 2021. By end user, the global biosurfactants market has been segmented into agricultural chemicals, household detergents, industrial & institutional cleaners, food processing, oilfield chemicals, textiles, cosmetics and personal care, others. The household detergents segment is estimated to account for the largest share of the global biosurfactants market. Geographically, the global biosurfactants market is segmented into Asia Pacific, Europe, North America, Rest of the World (RoW).
The global biosurfactants market is highly competitive. The prominent players operating in the global biosurfactants market include AGAE Technologies LLC, BASF SE, Biotensidon GmbH, Croda International PLC, Dow Chemical Company, Evonik Industries AG, GlycoSurf LLC, Jeneil Biotech Inc., Kaneka Corporation, Kao Corporation, Lion Corporation, Logos Technologies (Stepan Company), Nouryon B.V., People Against Dirty Holdings Limited (Ecover), Saraya Co. Ltd, Soliance SA (Givaudan S.A.), Synthezyme LLC, TeeGene Biotech.
The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the biosurfactants market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
Report Scope
Product: alkyl polyglucosides (APG), sorbitan esters, sucrose esters, rhamnolipids, sophorolipids, methyl ester sulfonates (MES), others
End user: agricultural chemicals, household detergents, industrial & institutional cleaners, food processing, oilfield chemicals, textiles, cosmetics and personal care, others
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028
Key Benefits for Stakeholders
– Get a comprehensive picture of the global biosurfactants market
– Pinpoint growth sectors and trends for investment
Table of Contents
Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Biosurfactants market overview
Part 3. Market breakdown by product
– Alkyl polyglucosides (APG)
– Sorbitan esters
– Sucrose esters
– Rhamnolipids
– Sophorolipids
– Methyl ester sulfonates (MES)
– Others
Part 4. Market breakdown by end user
– Agricultural chemicals
– Household detergents
– Industrial & institutional cleaners
– Food processing
– Oilfield chemicals
– Textiles
– Cosmetics and personal care
– Others
Part 5. Market breakdown by region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
Part 6. Key companies
– AGAE Technologies LLC
– BASF SE
– Biotensidon GmbH
– Croda International PLC
– Dow Chemical Company
– Evonik Industries AG
– GlycoSurf LLC
– Jeneil Biotech Inc.
– Kaneka Corporation
– Kao Corporation
– Lion Corporation
– Logos Technologies (Stepan Company)
– Nouryon B.V.
– People Against Dirty Holdings Limited (Ecover)
– Saraya Co. Ltd
– Soliance SA (Givaudan S.A.)
– Synthezyme LLC
– TeeGene Biotech
About StrategyHelix
Disclaimer
USD 650